Intravitreal bevacizumab versus ranibizumab: Effects on the vessels of the fellow non-treated eye.

Peyman, Mohammadreza; Peyman, Alireza; Lansingh, Van C; Orandi, Amirhossein; Subrayan, Visvaraja

Intravitreal bevacizumab versus ranibizumab: Effects on the vessels of the fellow non-treated eye.

Peyman, Mohammadreza; Peyman, Alireza; Lansingh, Van C; Orandi, Amirhossein; Subrayan, Visvaraja.

Afiliación

Peyman M; Parsian Vision Science Research Institute, Isfahan, Iran.
Peyman A; Department of Ophthalmology, Isfahan University of Medical Science, Isfahan, Iran.
Lansingh VC; VISION 2020 Latin America, International Agency for the Prevention of Blindness, Weston, FL, USA.
Orandi A; Tehran University of Medical Sciences, Tehran, Iran.
Subrayan V; Parsian Vision Science Research Institute, Isfahan, Iran.

J Curr Ophthalmol ; 31(1): 55-60, 2019 Mar.

Article en En | MEDLINE | ID: mdl-30899847

Palabras clave

Anti-vascular endothelial growth factors; Bevacizumab; Intravitreal; Ranibizumab; Systemic effect; Vessel diameter

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: J Curr Ophthalmol Año: 2019 Tipo del documento: Article País de afiliación: Irán Pais de publicación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google